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PURPOSE. This study was designed to develop and characterize a laser-induced model of acute
intraocular hypertension that permits the study of the anterior segment of the eye.
METHODS. CD1 mice aged 5 and 8 weeks were examined for elevation of IOP induced by laser
photocoagulation. We compared between occlusion of episcleral veins alone and when
combined with 2708 limbal vessel occlusion. Anterior chamber angle, corneal thickness, and
retinal nerve fiber layer (RNFL) thickness were evaluated by anterior- and posterior-segment
optical coherence tomography (OCT). Additionally, at day 7 post-procedure, the anterior
segment was evaluated for inflammatory cellular presentation by histologic analysis and OCT,
and limbal vessels and whole-mount retina were immunostained for CD31 and Brn3a,
respectively. Brn3a-positive retinal ganglion cells (RGCs) were quantified with ImageJ
software.
RESULTS. After single or combined laser treatment in mice aged 5 or 8 weeks, IOP was
significantly elevated for 5 to 6 days before returning to the baseline by day 7 post-procedure.
Anterior segment assessment indicated less synechiae in the anterior chamber angle and
better preserved limbal vessels with single versus combined laser treatment. Corneal
thickness was significantly increased after single or combined treatment. No inflammatory
cells were detected in the anterior chamber. The thickness of the RNFL and the density of
RGCs were both significantly reduced after single or combined treatment.
CONCLUSIONS. Laser photocoagulation of episcleral veins alone in CD1 mice aged 5 to 8 weeks
may be used to induce ocular hypertension resulting in RNFL thinning and ganglion cell loss.
This model permits the study of the anterior as well as the posterior segment of the eye.
Keywords: ocular hypertension, laser photocoagulation, glaucoma, animal model, episcleral
vein
Glaucoma is a leading cause of irreversible blindness. It isestimated that 111.8 million people will be affected by this
disease worldwide in 2040.1 Given its importance and multi-
facets, the mechanisms underlying glaucoma have been studied
extensively but are not yet fully understood.2–7 We recently
reported the first evidence that Schlemm’s canal, a critical
structure involved in aqueous humor drainage, expresses Prox-
1, the master control gene for lymphatic development.8 This
novel finding aligns well with several succeeding reports
showing that Schlemm’s canal is a VEGF-C/VEGFR-3 responsive
lymphatic-like vessel and Prox-1 determines its integrity and
identity.9,10 We are therefore interested in studying the
structures located at the anterior chamber angle and exploring
possible new mechanisms and therapeutic targets for glauco-
ma.
The purpose of this study was to develop a mouse model of
acute intraocular hypertension that permits the study of the
anterior segment of the eye. While a variety of mouse models
have been developed to establish elevated IOP for glaucoma
research, it is acknowledged that they are all bound by
limitations. Nevertheless, depending on the subject of interest,
it is possible to choose or develop a specific model to best
approach individual research goals. Recently, an animal model
of elevated IOP and glaucoma was developed by injection of
microbeads into the anterior chamber with subsequent
blockage of the aqueous humor outflow pathway.11–13 While
this model best suits studies of the posterior segment of the
eye, its application to the anterior segment is limited by
blockade and damage of the angle structures. Laser photoco-
agulation is another method to induce ocular hypertension.
This method was first developed in rats using a hand-held
ophthalmic cautery to induce chronic hypertension.14 It was
later reported that chronic hypertension can also be achieved
in mice using laser photocoagulation by targeting both the
limbus and the episcleral veins,15 by targeting the limbus
following anterior chamber cannulation,16 by targeting the
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trabecular meshwork through the limbus,17 or by targeting the
trabecular meshwork and the episcleral veins.18 Fu et al.19
reported a mouse model of acute ocular hypertension by laser
photocoagulation of both limbal and episcleral vessels, and
with this model, IOP elevation returns to normal within 1 week
post-procedure. All these models, whether of the acute or
chronic type, cause damage to the anterior chamber angles and
are thus not ideal for our research purpose.
In this paper, we present an acute ocular hypertension
model in CD1 mice using laser-induced occlusion of the
episcleral veins alone. This model, avoiding direct cautery on
limbal vessels or nearby structures, overcomes barriers of
other mouse models that hinder the study of the anterior
chamber angle. By comparative analysis between occlusion of
episcleral veins alone and when combined with 2708 limbal
vessel occlusion, we show that occlusion of episcleral veins
alone in CD1 mice is effective in inducing IOP elevation for 1
week, and this insult also leads to thinning of the retinal nerve
fiber layer (RNFL) and loss of retinal ganglion cells (RGCs).
More importantly, this model is associated with less synechiae
of the anterior chamber angle and thereby permits the study
of both anterior and posterior segments of the eye. Because
the structures of the iridocorneal angles of the mice mature
by postnatal days 35 to 42,20 we studied mice as early as 5
weeks of age. In addition, mice aged 8 weeks that are more
commonly used for adult stage study, were also investigated.
Our study revealed similar results between the groups. Taken
together, we have demonstrated that this model of laser-
induced occlusion of the episcleral veins alone can be used to
study both anterior and posterior segments of the eye, and it
can be used in CD1 mice aged 5 to 8 weeks. Further
investigations using this new model may facilitate the
discovery and development of new mechanisms and treat-
ment for glaucoma.
METHODS
Animals
Five- and eight-week-old male CD1 mice (Charles River
Laboratories, Wilmington, MA, USA) were used in the study.
All animals were treated according to the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research, and all
protocols were approved by the animal care and use
committee at the University of California, Berkeley. Mice were
anesthetized using a mixture of ketamine, xylazine, and
acepromazine (50 mg, 10 mg, and 1 mg/kg body weight,
respectively) for each surgical procedure. This was comple-
mented with topical anesthesia using 0.5% proparacaine
hydrochloride ophthalmic solution (Bausch & Lomb, Ro-
chester, NY, USA). Antibiotic ointment was applied after laser
treatment.
Measurement of Intraocular Pressure
Intraocular pressure was measured by a noninvasive TonoLab
tonometer (Icare Lab, Helsinki, Finland) under light general
anesthesia with 2% isoflurane. The measurement was per-
formed three times for each eye, with each instrument-
generated average derived from six effective IOP measure-
ments.
Laser Photocoagulation
Mice were randomized to receive unilateral laser photocoag-
ulation (532 nm, OcuLight TX; IRIDEX Corporation, Mountain
View, CA, USA) on the right eye using the parameter settings of
power, treatment duration, and spot number. As illustrated in
Supplementary Figure S1, for episcleral veins occlusion, the
setting is 300 mW 3 0.5 seconds 3 70 to 80 spots; for
combined laser photocoagulation with 2708 limbal vessels
(sparing nasal 908 aspect and long posterior ciliary artery), the
setting is 300 mW 3 0.5 seconds 3 110 to 120 spots. The left
eye was used as control. Intraocular pressure was measured
pre- and post-laser treatment for 7 consecutive days in both
eyes. Mice with IOP between 30 and 50 mm Hg in the right eye
at day 1 after laser treatment were included in subsequent
experiments. Mice of technical failure (i.e., hyphema) with IOP
above 50 mm Hg, which occurred rarely (4/153), were
excluded from the study.
Anterior and Posterior Segment Optical Coherence
Tomography
The analysis was performed as previously reported.21–24 For
evaluation of central corneal thickness and peripheral
anterior synechiae, an anterior-segment optical coherence
tomography (OCT; Visante OCT MODEL 1000; Carl Zeiss
Meditec, Dublin, CA, USA) was used. Quadrant-scans along
four axes (08–1808, 458–2258, 908–2708, and 1358–3158) were
performed to ensure scanning through the central cornea and
data along the 08 to 1808 axis were used for analysis. For
evaluation of RNFL thickness, upon pupil dilation with 1%
tropicamide ophthalmic solution (Akorn, Inc., Lake Forest, IL,
USA), a posterior segment OCT (Envisu R2300; Bioptigen,
Inc., Morrisville, NC, USA) was used to capture retinal cross-
section images. A rectangular scanning sequence (33 3 mm)
produced a single en face image of the retina using a
customized mouse lens (508 field of view), which consisted of
100 B-scan images (each B-scan comprised 1000 A-scans). The
B-scan images were analyzed with the manufacturer’s
InVivoVue Clinic software (Bioptigen, Inc.). Retinal nerve
fiber layer thickness was measured in 4 quadrants (nasal,
temporal, superior, and inferior) of the en face image by
masked observers. Measurements at 400 lm from the center
of the optic nerve head were performed within each
quadrant. Consequently, a total of four readings were
averaged to return a single thickness value. For evaluation
of inflammatory cells in the anterior chamber, eyes pre- and 7
days after laser treatment were examined by high-resolution
OCT and cellular presentation was evaluated as opaque dots
that did not adhere to the cornea, iris, or lens, as previously
reported.21,23
Hematoxylin and Eosin Stain
The experiment was performed as described previously.23,25–27
Laser-treated eyes at day 7 post-procedure were harvested and
embedded in optimal cutting temperature compound (Tissue-
Tek; Sakura Finetek, Torrance, CA, USA). Frozen sections (6
lm) were fixed with 4% paraformaldehyde and stained with
hematoxylin (Fisher Scientific, Pittsburgh, PA, USA) and eosin
(Leica Biosystems, Richmond, IL, USA) (H&E). Five to six
sections per animal were evaluated for the presence of
inflammatory cells in the anterior chamber.
Assessment of Limbal Vessels
The experiment was performed as described previously.24
Briefly, whole-mount limbal tissues were harvested at day 7
post-procedure, fixed in 4% paraformaldehyde, and immuno-
stained with primary rat-anti-mouse CD31 antibody (BD
Pharmingen, San Diego, CA, USA) that was visualized by
Cy3-conjugated donkey anti-rat secondary antibody (Jackson-
Immuno Research Laboratories, West Grove, PA, USA).
Samples were mounted with Vectashield mounting medium
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(Vector Laboratories, Burlingame, CA, USA) and examined by
an AxioImager M1 epifluorescence deconvolution micro-
scope with AxioVision 4.8 software (Carl Zeiss AG, Go¨ttingen,
Germany).
Assessment of Retinal Ganglion Cell Density
The experiment was performed as described previously.28
Briefly, whole-mount retinae were harvested at day 7 post-
procedure, fixed in methanol, and immunostained with
primary goat-anti-mouse Brn3a antibody (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), which was recognized by Cy3-
conjugated donkey anti-goat secondary antibody (Abcam,
Cambridge, MA, USA). Samples were mounted with Vecta-
shield mounting medium (Vector Laboratories) and examined
by the AxioImager M1 epifluorescence deconvolution micro-
scope with AxioVision 4.8 software (Carl Zeiss AG). For each
retina, eight areas were randomly selected at a distance of 850
lm from the optical disc for data analysis.29 Digital images
were analyzed to quantify the density of Brn-3aþ cells in each
area (6883 545 lm) using ImageJ software (http://imagej.nih.
gov/ij/; provided in the public domain by the National
Institutes of Health, Bethesda, MD, USA). The percentage
scores were obtained by normalizing to control condition
defined as being 100%.24
FIGURE 1. Intraocular pressure measurement with single or combined laser treatment in mice of 5 or 8 weeks of age. (A) Intraocular pressure
elevation after single or combined laser treatment, as compared with control contralateral eyes, in mice aged 5 (n¼ 13–17/group) or 8 (n¼ 10–12/
group) weeks. ***P < 0.001, **P < 0.01. (B) No significant difference was found between 5 (n¼13–17/group) and 8 (n¼10–12/group) weeks of age
with single versus combined treatment. n.s., not significant.
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Statistical Analysis
Data were reported as mean 6 SEM. The statistical significance
between two groups was assessed by Student’s t-test with
Prism software (GraphPad, La Jolla, CA, USA). Mann-Whitney U
test was performed for Figures 5 and 6. Fisher’ exact test was
used for Figure 2C and 3C with R Studio software (R Studio
Inc., Boston, MA, USA). P less than 0.05 was considered
significant.
RESULTS
Comparative Analysis of Elevation of Intraocular
Pressure Between Single and Combined Laser
Treatment and Between Mice Aged 5 and 8 Weeks
Intraocular pressure is an important risk factor of glaucoma.
We first set out to assess whether IOP elevation can be induced
by laser photocoagulation of the episcleral veins alone, and
how it compared with the combined treatment including
limbal vessels. Because structures of the iridocorneal angles
typically mature by postnatal day 35 to 42,20 we also compared
the results between CD1 mice at 5 or 8 weeks of age. Our
results on day 1 post-procedure showed that for mice 8 weeks
of age, the success rates for mice reaching IOP between 30 and
50 mm Hg after the single and combined treatment are 60%
and 63%, respectively, and the corresponding rates for mice 5
weeks of age are 61% and 70%, respectively. The mice with
IOP between 30 and 50 mm Hg were included for further
analysis.
As presented in Figure 1A, after single or combined laser
treatment with mice aged 5 or 8 weeks, IOP was significantly
elevated for 5 to 6 days before returning to the baseline by day
7 post-procedure. No significant difference was observed at
each time point between mice aged 5 or 8 weeks in single or
combined treatment (Fig. 1B). Our further analysis on short-
term IOP changes at 4, 10, and 24 hours after laser treatment
showed that IOP of the treated eyes was significantly elevated
at 4 hours post-procedure and it remained above that of the
control eyes at 10 and 24 hours post-procedure. No significant
difference was observed between the single or combined
treatment (Supplementary Fig. S2).
Comparative Analysis of Peripheral Anterior
Synechiae Between Single and Combined Laser
Treatment and Between Mice Aged 5 and 8 Weeks
We next examined peripheral anterior synechiae (PAS) in the
anterior chamber angle with anterior segment OCT,17 and
FIGURE 2. Anterior-segment OCT evaluation of central corneal
thickness and anterior chamber angles in mice age 5 weeks. (A)
Representative OCT images showing central corneal thickness and
anterior chamber angles pre- (Day 0) and post-laser treatment on days 1
and 7 after the single or combined procedure. White circle indicates
normal anterior chamber angle; red circle indicates synechiae at the
angle with iris flattening; blue bar indicates site of measurement for
central corneal thickness. Scale bar: 1 mm. (B) Summarized data
showing significantly lower rate of synechiae in single than combined
treatment. *P < 0.05 (n ¼ 13–17/group). (C) Summarized and
comparative data showing increased central corneal thickness at day
1 after single or combined treatment. No significant difference was
found at day 7 after the procedures. ***P < 0.001. n.s., not significant (n
¼ 10–12/group).
FIGURE 3. Anterior-segment OCT evaluation on central corneal
thickness and anterior chamber angles in mice aged 8 weeks. (A)
Representative OCT images showing central corneal thickness and
anterior chamber angles pre- (Day 0) and post-laser treatment on days
1 and 7 after the single or combined procedure. White circle indicates
normal anterior chamber angle; red circle indicates synechiae at the
angle with iris flattening; blue bar indicates site of measurement for
central corneal thickness. Scale bar: 1 mm. (B) Summarized data
showing significantly lower rate of synechiae in single than combined
treatment. *P < 0.001 (n ¼ 10–12/group). (C) Summarized and
comparative data showing increased central corneal thickness at day
1 after single or combined treatment. No significant difference was
found at day 7 after the procedures. ***P < 0.001. n.s., not significant
(n ¼ 10–12/group).
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compared the results between single and combined laser
treatment, and between mice of 5 and 8 weeks of age. The
presence of PAS with flattening iris,30 as demonstrated by
representative OCT images in Figures 2A and 3A (red circles in
lower panels), indicates laser-induced adherence of iris tissue
to the nearby angle structures after the insult. As summarized
in Figure 2B and 3B, our results from mice aged 5 weeks
showed significantly higher incidence of PAS in the combined
versus single treatment setting (82.35% vs. 7.69%), and this
dramatic difference was also observed in mice aged 8 weeks
(91.67% vs. 10.0%). Taken together, these data suggest that
single laser treatment results in fewer PAS than the combined
treatment.
Comparative Analysis of Central Corneal
Thickness Between Single and Combined Laser
Treatment and Between Mice Aged 5 and 8 Weeks
We also evaluated the thickness of the central cornea using
anterior-segment OCT, an important parameter associated with
IOP elevation and corneal edema. Our results in mice of 5 and
8 weeks of age (Figs. 2C and 3C, respectively) showed a similar
pattern where corneal thickness was significantly increased
with peak IOP at day 1 after single or combined treatment. By
day 7 when IOP returned to baseline, no significant difference
was detected with corneal thickness between treated and
control eyes, in all experimental settings.
Assessment of Inflammatory Cells in the Anterior
Chamber
Previously, it was reported that black Swiss mice after laser
treatment at the limbus showed no evidence of inflammation
in the anterior segment.26 In this study with the CD1 mice, we
performed histologic analysis of laser-treated eyes on day 7
post-procedure with H&E staining, as previously reported.23
While our results confirmed the presence of PAS with
combined laser treatment, no inflammatory cells were
detected in the anterior chamber after single or combined
laser treatment in mice aged 5 or 8 weeks (Supplementary Fig.
S3). This negative result was also confirmed by high-resolution
OCT where no cellular presentation, defined as opaque dots
that did not adhere to the cornea, iris, or lens,21,23 was
detected in the anterior chamber (Supplementary Fig. S4).
Assessment of Limbal Vessels
To assess the condition of limbal vessels after single or
combined laser treatment, we performed immunofluorescent
FIGURE 4. Posterior-segment OCT evaluation on the thickness of
RNFL after single or combined laser treatment in mice aged 5 or 8
weeks. (A) Representative OCT image showing a normal retina of a
CD1 mouse. Yellow cross shows the measurement location at 400-lm
distance from the optic nerve head. Scale bar: 500 lm. (B)
Representative posterior-segment OCT image of the RNFL layer and
total retina in a normal CD1 mouse. Scale bar: 100 lm. (C)
Summarized data showing significant reduced RNFL thickness at
day 7 post procedure in mice aged 5 or 8 weeks in both single and
combined treatment settings. *P < 0.05 (n¼ 16–18/group). IPL, inner
plexiform layer; ONL, outer nuclear layer.
FIGURE 5. Immunofluorescent microscopic analysis of retinal gangli-
on cell loss after single or combined treatment in mice aged 5 weeks.
(A) Representative images showing reduced Brn3aþ cells (red) in the
retina 7 days after single (upper panels) or combined (lower panels)
laser treatment, as compared with untreated contralateral retina.
Scale bar, 100 lm. Summarized data are presented in (B) and (C) for
single and combined treatment, respectively. ***P < 0.001 (n ¼ 9/
group).
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microscopic analysis using specific antibody against CD31, a
panendothelial cell marker. As shown in Supplementary Figure
S5, compared with combined treatment that resulted in
significant loss of limbal vessels upon laser photocoagulation,
single treatment better preserved these vessels, and this effect
was observed in mice aged 5 and 8 weeks.
Comparative Analysis of Loss of Retinal Nerve
Fibers Between Single and Combined Laser
Treatment and Between Mice Aged 5 and 8
Weeks
The above data indicate that single laser occlusion of episcleral
veins alone is effective in inducing acute IOP elevation and
meanwhile preserving the anterior segment. Because glaucoma
is a disease associated with optic nerve damage, we next
assessed thinning of the RNFL by posterior segment OCT, and
compared the results between single and combined laser
treatment, and between mice of 5 and 8 weeks of age. As
presented in Figure 4, this set of experiments again revealed a
similar pattern between single and combined treatment, and
between 5 and 8 weeks of age. The RNFL thickness at day 7
post-procedure was significantly reduced compared with day 0
in all experimental groups.
Comparative Analysis of Loss of Retinal Ganglion
Cells Between Single and Combined Laser
Treatment and Between Mice Aged 5 and 8 Weeks
Finally, we performed immunofluorescent microscopic assays
with whole-mount retina and analyzed RGC loss with single
and combined treatment, and with mice of 5 and 8 weeks of
age (Figs. 5, 6). As demonstrated in Figures 5A and 6A, our
results showed a significant reduction of Brn3aþ cells in all
experimental settings. In mice 5 weeks of age, the density of
Brn3aþ cells after single or combined treatment was decreased
by 33.02% and 36.67%, respectively, compared with control. A
similar pattern was observed with mice 8 weeks of age, and the
corresponding reduction rates are 30.04% and 36.8%, respec-
tively.
DISCUSSION
In summary, we have presented in this study a new mouse
model of laser photocoagulation with occlusion of the
episcleral veins alone. This model is effective in the induction
of acute intraocular hypertension, RNFL thinning, and RGC
loss. Compared with the combined model of laser photocoag-
ulation that requires additional occlusion of the limbal vessels,
this single treatment model is of smaller scale and less invasive.
More importantly, because this procedure spares the limbal
area, it reduces the incidence of PAS and leave the anterior
chamber angles open. This study thus offers a new model that
permits the study of the anterior segment of the eye in addition
to the posterior segment.
In this study, we assessed age as a factor and compared mice
5 and 8 weeks of age. Because structures of iridocorneal angles
of mice mature by postnatal day 35 to 42,20 and our results
demonstrate elevated IOP in both age groups, the laser model
should be effective with mice aged 5 to 8 weeks. Considering a
previous study demonstrating that there is no significant
difference in IOP between CD1 mice 2- and 10-months old,31 it
may be possible to extend the working range of this laser
model to 10 months of age, which warrants further investiga-
tion.
Our model of single or combined treatment is able to
induce IOP elevation within the first day before it returns to
baseline levels in 1 week. This week-long period of IOP
elevation causes a significant reduction of RGCs by 30% to
40%. Previously, hand-held cautery models were reported in
rats and CD1 mice, respectively, by surgical incision through
the conjunctiva and Tenon’s capsule. Intraocular pressure
elevation was achieved within the first day and remained
elevated for 2.5 months in rats and 4 weeks in CD1 mice,
respectively.14,32 While these models induce sustained IOP
elevation, it is a more challenging procedure with invasive
surgery that is associated with damage of surrounding tissues.
In this study, as suggested by a previous report on combined
laser treatment, we spared nasal 908 of the limbal vessels and
the long posterior ciliary artery to avoid acute IOP spikes (>70
mm Hg within 12 hours) that could lead to severe ischemic
changes, and we did not repeat the laser treatment to extend
the period of IOP elevation to avoid ocular inflammation.19
Our model of week-long elevation of IOP is already successful
in inducing RGC loss and RNFL thinning. Our week-long
duration of IOP elevation is consistent with the previous
reports on combined laser treatment in albino CD1 or Swiss
mice.19,33 While one study19 reports no significant loss of RGCs
at 1 week post-procedure though a trend of decrease is
observed, the other study33 shows significant loss of RGCs
around 1 week post-procedure. The disparity among the
studies may be due to different thresholds used in analysis. We
FIGURE 6. Immunofluorescent microscopic analysis of RGC loss
after single or combined treatment in mice aged 8 weeks. (A)
Representative images showing reduced Brn3aþ cells (red) in the
retina 7 days after single (upper panels) or combined (lower panels)
laser treatment, as compared with untreated contralateral retina.
Scale bar: 100 lm. Summarized data are presented in (B) and (C) for
single and combined treatment, respectively. ***P < 0.001 (n ¼ 9/
group).
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set a threshold value of IOP at 30 mm Hg on day 1 after laser
treatment because our preliminary experiments indicate no
significant loss of RGCs in mice with IOP below this threshold.
Our data on loss of RGCs align well with thinning of the RNFL,
which is also apparent at 1 week post-procedure. In this study,
we also observed pupil dilation upon IOP elevation, as
reported previously.18 This may be due to compromised pupil
sphincter upon IOP elevation because iris blood vessels are not
autoregulated.34,35 This phenomenon is also seen in patients of
acute glaucoma.
Taken together, we have developed a new mouse model of
laser coagulation that can be used to study both the anterior
and posterior segment of the eye and can be employed in
mice aged 5 to 8 weeks, and possibly older. This model
recapitulates key parameters associated with acute glaucoma
and can potentially be used to study this disease from various
aspects.
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